The First Hip Replacement Is Also a Revision Decision

Why Does the First Hip Replacement Matter to a Future Revision?

A primary total hip arthroplasty is performed to solve the patient’s current problem—not to prepare for an inevitable revision.

But the first operation changes the anatomy that any future surgeon may inherit.

Femoral preparation removes bone. Acetabular reaming changes available bone stock. Component position establishes a new biomechanical reference. Implant choice can also influence what may later be retained, exchanged or revised.

The practical principle is straightforward:

A primary hip should solve today’s reconstruction reliably without unnecessarily making tomorrow’s reconstruction more difficult.

This does not mean choosing the smallest implant or minimizing bone preparation at the expense of fixation.

The current reconstruction comes first.

But when more than one clinically sound option exists, preserving healthy bone and maintaining reasonable future flexibility can have long-term value.

Five Primary Choices That May Matter Years Later

The relationship between primary THA and revision is easier to understand when viewed as a sequence of decisions:

• Femoral preparation → future host bone: unnecessary bone removal today may reduce the bone available for later fixation.

• Acetabular preparation → future reconstruction space: aggressive reaming can influence what remains if cup revision is eventually required.

• Offset and leg length → future biomechanics: a later surgeon inherits the mechanical reconstruction created during the first operation.

• Implant compatibility → partial revision options: a well-fixed component may sometimes be retained only if compatible revision components remain available.

• Implant documentation → future planning: accurate records of component type, size and fixation can make later identification and revision planning easier.

Bone preservation should never compromise current stability.

The better principle is:

Preserve what can reasonably be preserved after the requirements for reliable primary fixation have been met.

Data Snapshot 1: Revision Is Uncommon, but It Is a Large Clinical Problem

The scale of national registry data explains why lifetime reconstruction matters.

The National Joint Registry (NJR) 22nd Annual Report 2025 analyzed 1,682,998 primary hip replacements performed between 2003 and 2024. Of these, 50,946 first revisions could be linked to a primary hip replacement already recorded in the registry. In 2024 alone, the NJR recorded 116,901 primary hip replacements and 7,253 hip revision procedures.

These figures should not be interpreted as an individual patient’s probability of revision.

They show something different:

Even when revision is uncommon at the individual level, it becomes a substantial reconstructive workload when primary THA is performed at population scale.

Revision also occurs for different reasons. Across NJR revision procedures, major indications include aseptic loosening, dislocation or subluxation, periprosthetic fracture, infection, wear and other mechanical or biological problems.

The primary operation therefore needs to succeed on two levels:

solve the current reconstruction

and

avoid creating unnecessary difficulty if the hip ever needs to be revised.

Data Snapshot 2: Long-Term Evidence Matters More Than “Newness”

The NJR also provides an important benchmark for how mature primary hip reconstruction should be evaluated.

For primary hip replacements performed in 2014, the estimated cumulative revision rate at 10 years was 2.7% (95% CI 2.6–2.8).

NICE recommends total hip replacement prostheses with an observed or projected revision rate of 5% or less at 10 years.

The Orthopaedic Data Evaluation Panel (ODEP) has a different role. It evaluates the strength and duration of implant evidence; its 10A* pathway is aligned with tracking toward no more than a 5% revision rate over 10 years. ODEP should therefore be understood as an implant evidence-rating framework rather than simply another name for the NICE threshold.

This distinction matters for hospitals.

A new stem geometry, porous coating or manufacturing technology should not be considered valuable simply because it is new.

The better questions are:

What clinical problem does the design solve?

How mature is the evidence for the exact implant?

What happens if that reconstruction later requires revision?

Innovation matters most when it can be connected to a defined clinical need and credible product-specific evidence.

Data Snapshot 3: What Established Global Hip Systems Show

Large registry datasets also illustrate why evidence should follow the specific construct, not just the brand name.

For example, the 2025 NJR reports the following ceramic-on-polyethylene (CoP) constructs:

NJR 2025 construct example	Procedures	10-year cumulative revision
CORAIL + Articul/eze + PINNACLE liner + PINNACLE Gription shell, CoP	9,722	1.82% (95% CI 1.41–2.34)
Exeter V40 + V40 head + Trident liner + Trident Cementless shell, CoP	90,325	1.83% (95% CI 1.68–1.99)

The first construct comes from the DePuy Synthes / Johnson & Johnson hip portfolio, while Exeter and Trident are Stryker systems.

These numbers must not be interpreted as a head-to-head DePuy-versus-Stryker comparison.

The patient populations, fixation concepts, implant combinations, treatment periods and other clinical variables differ.

Their real significance is more useful:

Established orthopedic systems are increasingly judged at the level of the actual implant construct, supported by large case volumes and long follow-up.

This creates an important benchmark for every orthopedic manufacturer.

The strongest international positioning is therefore not:

“Our implant is more advanced.”

It is:

Here is the design rationale, here is the fixation philosophy, here is the Surgical Technique, here is the product-specific evidence, and here is how the system supports reconstruction if complexity increases.

Revision May Require a Different Fixation Philosophy

The anatomy available at revision may be very different from the anatomy present during the primary procedure.

The surgeon may encounter:

bone loss, an enlarged femoral canal, cortical defects, altered version, compromised metaphyseal support or a previous prosthetic bed.

At that point, simply choosing a larger primary stem may not solve the problem.

The fixation target itself may need to change.

A revision construct may need to obtain fixation in more reliable distal bone. In other cases, modularity may help address version, offset, leg length or proximal-distal mismatch.

AK Medical’s current revision portfolio reflects several of these reconstruction principles.

The AK-SL Femoral Stem, for example, uses cementless distal fixation with a 2° taper and is offered in two lengths and 16 sizes. AK Medical’s AK-ABM System adds a modular proximal-distal concept, while the AK-Ringfix Cup and 3D ACT Augments extend the pathway to complex acetabular reconstruction.

These products should not be interpreted as options that every primary patient will eventually require.

They illustrate the difference between:

primary fixation

and

revision reconstruction when the original fixation environment no longer exists.

A revision implant is not simply a larger primary implant.

Why Getting the First Reconstruction Right Matters

Revision surgery also changes the long-term risk environment.

In the 2025 NJR, hips that underwent their first revision within one year of the primary procedure had an estimated 19.35% cumulative risk of re-revision at 10 years after that first revision.

When the primary hip had survived for 10 years or more before the first revision, the corresponding 10-year re-revision estimate was 8.99%.

These data show an association, not proof that the original implant choice caused the difference.

Early revision can reflect infection, instability, fracture, patient factors, surgical factors and other diagnoses.

But the broader message is difficult to ignore:

Once a hip enters the revision pathway, the reconstruction becomes harder to sustain over time.

That makes primary reconstruction quality particularly important.

The objective is not to predict every future revision.

It is to avoid preventable compromises during the operation in which the surgeon has the best bone and the greatest reconstructive freedom.

Where AK Medical Fits: From Primary THA to Revision Reconstruction

AK Medical’s current hip portfolio spans primary replacement, cemented implants and revision reconstruction. The official product portfolio lists primary systems including AK-CL, AK-ML and AK-SR, a cemented ACP femoral stem, and revision solutions including AK-ABM, 3D ACT Augments, AK-SL and AK-Ringfix.

That allows a hospital to evaluate more than one isolated implant.

For primary THA, the discussion may focus on:

stable fixation, bone preparation, component position, offset, leg length and bearing selection.

If revision becomes necessary, the questions change:

Where is reliable host bone still available?

Can an existing component remain?

Is distal fixation required?

Is modular adjustment useful?

Does the acetabulum now require additional fixation or defect reconstruction?

The useful lifetime principle is:

Use the least complex reconstruction that reliably solves the current problem while preserving reasonable future options.

Explore Primary and Revision Hip Reconstruction

Explore AK Medical Hip Reconstruction Solutions

For a specific primary or revision hip case, product information, market-specific regulatory documentation or technical discussion:

Discuss a Hip Reconstruction Case with the AK Medical International Team

AK Medical’s official international contact page currently lists sales@ak-medical.net and WhatsApp +86 150 0110 2275 for overseas enquiries.

Frequently Asked Questions

Does every primary hip replacement need to be planned as though revision is inevitable?

No. The goal is to create the best primary reconstruction for the patient today. Lifetime planning means avoiding unnecessary loss of bone or future flexibility once reliable fixation has been achieved.

Does bone preservation mean choosing a smaller implant?

No. Implant size and preparation must first satisfy the fixation requirements of the case.

Why does component compatibility matter?

Because future revision may involve only part of the reconstruction. The ability to retain a well-fixed component can depend partly on compatible heads, liners or revision options.

Why are registry data useful?

Registries provide large-volume, long-term evidence about real-world implant constructs. They complement—but do not replace—clinical studies, Surgical Techniques and patient-specific decision-making.

Can the Stryker and DePuy NJR results above be directly compared?

No. They are registry examples, not randomized head-to-head evidence. Differences in patients, implant combinations and clinical practice prevent a simple brand-ranking interpretation.

Does having a large revision portfolio make a primary hip system better?

Not automatically. Primary performance must be supported independently. A revision portfolio becomes relevant when it provides useful options if fixation, bone stock or anatomy later change.

What should a hospital evaluate beyond the primary implant price?

Long-term evidence, instruments, component compatibility, revision pathways, regulatory documentation, inventory, supply reliability and clinical support can all affect the practical value of a hip platform.

Professional Notice

This article is intended for professional education, clinical technology evaluation and hospital procurement discussion. It does not constitute patient-specific medical advice.

Registry data describe populations and specific implant constructs and should not be interpreted as predictions for an individual patient. Observational comparisons between different implant systems, fixation strategies or bearing combinations do not establish clinical superiority unless supported by an appropriate comparative study design.

Product specifications, indications, contraindications, warnings, compatibility, regulatory status and availability may vary by market and may change over time.

Treatment and implant selection should be determined by appropriately qualified clinicians using the applicable Instructions for Use, Surgical Technique, patient-specific clinical information and local regulatory requirements.